Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21812663 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids
Condition: Asthma
Interventions: Drug: lebrikizumab (MILR1444A);   Drug: placebo

Indicates status has not been verified in more than two years